286P Artificial intelligence analysis of advanced breast cancer patients from a phase I trial of trastuzumab deruxtecan (T-DxD): HER2 and histopathology features as predictors of clinical benefit
2020 ◽
Vol 31
◽
pp. S355-S356
S. Modi
◽
B. Glass
◽
A. Prakash
◽
A. Taylor-Weiner
◽
H. Elliott
◽
...
2005 ◽
Vol 16
(7)
◽
pp. 1087-1093
◽
E. Mrózek
◽
C.A. Rhoades
◽
J. Allen
◽
E.M. Hade
◽
C.L. Shapiro
1994 ◽
Vol 35
(2)
◽
pp. 174-178
H. St�ger
◽
Thomas Bauernhofer
◽
Marianne Schmid
◽
Ferdinand Ploner
◽
Renate Moser
◽
...
1994 ◽
Vol 35
(2)
◽
pp. 174-178
◽
Herbert St�ger
◽
Thomas Bauernhofer
◽
Marianne Schmid
◽
Ferdinand Ploner
◽
Renate Moser
◽
...
2020 ◽
Vol 31
◽
pp. S351-S352
B. Krastev
◽
R. Rai
◽
I. Bulat
◽
M. Maglakelidze
◽
C. Murias
◽
...
2010 ◽
Vol 67
(3)
◽
pp. 687-693
◽
Patrizia Vici
◽
Alessandra Fabi
◽
Giulio Metro
◽
Domenico Sergi
◽
Diana Giannarelli
◽
...
Tammy A. Schuler
◽
Barbara L. Andersen
PA Fasching
◽
MP Lux
◽
L Häberle
◽
M Wallwiener
◽
A Schneeweiss
◽
...
Javier Silva
◽
Vanesa García
◽
José M García
◽
Cristina Peña
◽
Gemma Domínguez
◽
...
Close
Export Citation Format
Close
Share Document
Close